CLINICAL_TRIALS
trial_result
· 2026-07-23
Clinical Trial Results: TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment [Phase 2]
Summary
Phase 2 trial evaluating rifapentine during the intensive phase of tuberculosis treatment completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centers for Disease Control and Prevention | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2026-07-23